Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-25T00:28:15.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed study purpose and inclusion/exclusion criteria for a clinical trial on urothelial cancer, while retaining key information about the study's unblinding process and collaborators.
    Difference
    14%
    Check dated 2025-04-17T17:11:41.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-10T13:54:25.000Z thumbnail image
  5. Check
    36 days ago
    No Change Detected
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-03-27T05:40:56.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-26T08:20:31.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-11T22:50:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.